|
|
|
|
| LEADER |
06749nam a22005055i 4500 |
| 001 |
978-981-13-1391-2 |
| 003 |
DE-He213 |
| 005 |
20210624213641.0 |
| 007 |
cr nn 008mamaa |
| 008 |
181103s2018 si | s |||| 0|eng d |
| 020 |
|
|
|a 9789811313912
|9 978-981-13-1391-2
|
| 024 |
7 |
|
|a 10.1007/978-981-13-1391-2
|2 doi
|
| 050 |
|
4 |
|a QR251-255
|
| 072 |
|
7 |
|a MMFP
|2 bicssc
|
| 072 |
|
7 |
|a MED103000
|2 bisacsh
|
| 072 |
|
7 |
|a MKFP
|2 thema
|
| 082 |
0 |
4 |
|a 616.96
|2 23
|
| 245 |
1 |
0 |
|a Lymphatic Filariasis
|h [electronic resource] :
|b Epidemiology, Treatment and Prevention - The Indian Perspective /
|c edited by Brij Kishore Tyagi.
|
| 250 |
|
|
|a 1st ed. 2018.
|
| 264 |
|
1 |
|a Singapore :
|b Springer Singapore :
|b Imprint: Springer,
|c 2018.
|
| 300 |
|
|
|a XIX, 314 p. 57 illus., 43 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a 1. Epidemiology of lymphatic filariasis -- 2. Lymphatic filariasis - prevalence, prevention control and elimination: a review in Indian scenario -- 3. Next step lymphatic filariasis eradication: Current status in the development of a vaccine against lymphatic filariasis -- 4. Progress in the treatment and control of lymphatic filariasis -- 5. Immunotechnological advancement in developing vaccines for Lymphatic Filariasis -- 6. Recombinant filarial, Wolbachia antigens and their role in the immunopathogenesis of human lymphatic filariasis -- 7. Transmission Potential of Wuchereria bancrofti by Culex quinquefasciatus in Malaysia and its global significance -- 8. Genetic diversity, molecular markers and population genetics of human lymphatic filarial parasites -- 9. Transmission dynamics of diurnally subperiodic lymphatic filariasis in the Andaman & Nicobar Islands -- 10. Success story and challenges faced to achieve ‘Elimination of Lymphatic Filariasis’ Status in Tamil Nadu -- 11. Prevalence of lymphatic filariasis in the northeastern States of India, with particular reference to Assam and prospects of elimination -- 12. An overview of lymphatic filariasis in Puducherry Union Territory, highlighting the elimination programme in India -- 13. Sporadic incidence of lymphatic filariasis in non-endemic state of Rajasthan and control of the vector (Culex quinquefasciatus Say, 1823), with innovative botanicals and a possible hypothesis on spread of ‘disease endemism’ -- 14. Integrated vector control for the elimination of lymphatic filariasis in the villages of Tirukoilur, south India -- 15. The Indian lymphatic filariasis elimination programme - the success to sustain -- 16. Bioecology, insecticide susceptibility and management of Culex quinquefasciatus Say, 1823, a major vector of lymphatic filariasis in India -- 17. Ecology and biology of Culex quinquefasciatus Say, 1823, in two physiographically different ecosystems with special reference to human lymphatic filariasis in West Bengal, India -- 18. Actinobacteria: A promising biocontrol agent for filariasis vector, Culex quinquefasciatus Say, 1823 (Insecta: Diptera; Culicidae) -- 19. Nanopesticides: A boon towards the control of dreadful vectors of lymphatic filariasis -- 20. Identification and mapping of breeding habitats of the filariasis vector, Culex quinquefasciatus Say, 1823, using Remote Sensing and GIS Technologies – A Case Study from the endemic Tamil Nadu state, India -- 21. Scenario of lymphatic filariasis (LF) in Bangladesh: a scientific approach -- 22 . Biological Control of Culex quinquefasciatus Say, 1823 (Diptera: Culicidae), the ubiquitous vector for lymphatic filariasis -- 23. Chemical control of Culex quinquefasciatus (Say, 1823), the principal vector of bancroftian filariasis, with emphasis on resistance development against insecticides in India -- 24. Perspectives of lymphatic filariasis with special reference to ‘Sleepada’ - An Ayurvedic loom.
|
| 520 |
|
|
|a Lymphatic Filariasis (LF) is a group of human and animal infectious diseases caused by nematode parasites of the order Filariidae. Often neglected, it is one of the oldest and the most debilitating tropical diseases (NTDs), transmitted from human to human by mosquitoes bites, particularly the brown black mosquito known as Culex quinquifasciatus. LF is a major public health problem in many parts of the tropics, especially India, which accounts for as much as 40% of total global cases. As a leading cause of permanent and long-term disability worldwide, the parasite infection imposes a severe physical and socioeconomic burden. The World Health Organization (WHO) estimates that 1.4 billion people live in high-risk areas – 120 million of which are already infected with LF, including 22 million children below the age of 15 and about 76 million who suffer from damaged lymphatic and renal systems. India has made great strides toward eliminating the disease, and these advances are of global significance. They include early diagnosis mechanisms, vaccine product development, detection of parasites in the vector, and studies on parasite evolution trends in nature as warning signals. Reports on the successes and failures are needed to enable measures to be taken to avoid disaster and ensure a smooth transition from endemicity in India to the elimination of lymphatic filariasis by 2020. This book, which gathers highly original contributions on various subjects related to lymphatic filariasis, discusses the latest scientific research that will help the nation to achieve this milestone. It also serves as a guide to many other countries struggling against this highly debilitating and incapacitating disease.
|
| 650 |
|
0 |
|a Parasitology.
|
| 650 |
|
0 |
|a Infectious diseases.
|
| 650 |
|
0 |
|a Tropical medicine.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
1 |
4 |
|a Parasitology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B19002
|
| 650 |
2 |
4 |
|a Infectious Diseases.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33096
|
| 650 |
2 |
4 |
|a Tropical Medicine.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H61006
|
| 650 |
2 |
4 |
|a Immunology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000
|
| 700 |
1 |
|
|a Tyagi, Brij Kishore.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer Nature eBook
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811313905
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811313929
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-13-1391-2
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 912 |
|
|
|a ZDB-2-SXB
|
| 950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
| 950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|
